AQST:NASDAQ, Aquestive Therapeutics, Inc.

AQST stock overview

Aquestive Therapeutics, Inc. (AQST:NASDAQ) closed at $3.83 on October 19, 2026, up 1.32% on the day. The stock trades 49.3% below its 52-week high of $7.55 and 30.7% above its 52-week low of $2.93. Over the past year, it lost 48.9%. Aquestive Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$3.83
Day change
+1.32%
Volume
3,331,975
Average volume
2,751,539
Market cap
480M+
52-week range
$2.93 – $7.55
50-day average
$4.71
200-day average
$4.27

Price action over the past year

In 252 trading sessions since October 17, 2025, AQST closed higher on 115 days (46%). Its best day was February 2, 2026 (+38.98%) and its worst was January 9, 2026 (-37.04%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

AQST news

About Aquestive Therapeutics, Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company that advances and commercializes medicines to solve critical health care problems.

Similar stocks

Find more stocks like AQST with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.